Joachim Müller-Quernheim
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Boesing M, Abig K, Brändle M, Brutsche M, Burri E, Frye B, Giezendanner S, Grutters J, Haas P, Heisler J, Jaun F, Leuppi-Taegtmeyer A, Lüthi-Corridori G, Müller-Quernheim J, Nüesch R, Pohl W, Rassouli F, Leuppi J. Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial. Trials 2022; 23:790.
Sep 20, 2022Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Sep 20, 2022Trials 2022; 23:790
Boesing Maria, Abig Kristin, Brändle Michael, Brutsche Martin, Burri Emanuel, Frye BjöC, Giezendanner Stéphanie, Grutters Jan C, Haas Philippe, Heisler Justian, Jaun Fabienne, Leuppi-Taegtmeyer Anne Barbara, Lüthi-Corridori Giorgia, Müller-Quernheim Joachim, Nüesch Reto, Pohl Wolfgang, Rassouli Frank, Leuppi Jörg D
Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk
Fischer A, Nöthen M, Herms S, Gieger C, Strauch K, Winkelmann J, Boehm B, Brand S, Büning C, Schürmann M, Ellinghaus E, Baurecht H, Lieb W, Nebel A, Müller-Quernheim J, Franke A, Schreiber S, Homolka J, Sterclova M, Ellinghaus D, Nutsua M, Hofmann S, Montgomery C, Iannuzzi M, Rybicki B, Petrek M, Mrazek F, Pabst S, Grohé C, Grunewald J, Ronninger M, Eklund A, Padyukov L, Mihailovic-Vucinic V, Jovanovic D. Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk. Am J Respir Crit Care Med 2015; 192:727-36.
Sep 15, 2015Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk
Sep 15, 2015Am J Respir Crit Care Med 2015; 192:727-36
Fischer Annegret, Nöthen Markus M, Herms Stefan, Gieger Christian, Strauch Konstantin, Winkelmann Juliane, Boehm Bernhard O, Brand Stephan, Büning Carsten, Schürmann Manfred, Ellinghaus Eva, Baurecht Hansjörg, Lieb Wolfgang, Nebel Almut, Müller-Quernheim Joachim, Franke Andre, Schreiber Stefan, Homolka Jiri, Sterclova Martina, Ellinghaus David, Nutsua Marcel, Hofmann Sylvia, Montgomery Courtney G, Iannuzzi Michael C, Rybicki Benjamin A, Petrek Martin, Mrazek Frantisek, Pabst Stefan, Grohé Christian, Grunewald Johan, Ronninger Marcus, Eklund Anders, Padyukov Leonid, Mihailovic-Vucinic Violeta, Jovanovic Dragana
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement
Baughman R, Barnathan E, Oemar B, Lo K, Flavin S, Schlenker-Herceg R, Müller-Quernheim J, Donohue J, Davis G, Brutsche M, Albera C, du Bois R, Costabel U, Judson M, Kavuru M, Drent M, Sarcoidosis Investigators. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. American journal of respiratory and critical care medicine 2006; 174:795-802.
Oct 1, 2006Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement
Oct 1, 2006American journal of respiratory and critical care medicine 2006; 174:795-802
Baughman Robert P, Barnathan Elliot S, Oemar Barry, Lo Kim Hung, Flavin Susan, Schlenker-Herceg Rozsa, Müller-Quernheim Joachim, Donohue James F, Davis Gerald, Brutsche Martin, Albera Carlo, du Bois Roland, Costabel Ulrich, Judson Marc A, Kavuru Mani, Drent Marjolein, Sarcoidosis Investigators